Cardiologist & Innovator: PASSION = CMRCTEcho STEMI Trials. “Prescribing the Future by Today’s Research” 🇮🇳🇺🇸

Joined May 2020
29 Photos and videos
Pinned Tweet
“MIRON-TROP Clinical Trial in “New England Journal of Medicine - Evidence” evidence.nejm.org/doi/full/1… First Ever: Troponin is no longer just a marker of any MI — Post-PCI Troponin is a precision diagnostic method to identify Hemorrhagic MI. @rohandkumar1 @IUMedSchool @IURadiology
2
121
It was an excellent clinical conference at the SCMR 29th Annual Scientific Sessions at Rio de Janeiro, Brazil to present our latest trials showcasing the critical role of Cardiovascular MRI in STEMI care. @IURadiology @IUMedSchool @IU_Health @rohandkumar1 @SCMR @BrunoLimaMDPhD
71
MIRON-TROP trial at #TCT2025 San Francisco Our research identifies a key driver of in-hospital mortality post-PCI: hemorrhagic myocardial infarction. We found that post-procedural troponin kinetics can be used to diagnose this critical stage of MI Thank you @CRFheart & @TCTMD
2
2
764
Hemorrhagic MI is why STEMI needs a pre-PCI checkpoint. Treat speed wisdom: before PCI, hold the cine, watch collaterals, record Rentrop. A small pause that upgrades CCU triage, imaging, and follow-up. Rentrop in every Cath report of MI. MIRON-CL Trial sciencedirect.com/science/ar…
1
13
59
6,673
Keyur P. Vora retweeted
Intramyocardial hemorrhage following primary PCI is a major predictor of adverse cardiovascular outcomes but is difficult to diagnose in real time. Vora et al. describe the use of post-PCI troponin kinetics to make the diagnosis. eviden.cc/47FEcTI
6
24
12,204
Honored to present #ESCAbstract on the #ESCCongress along with NEJM Evidence - MIRON TROP Trial Publication !!! esc2025-abstract.medicalcong… Hemorrhagic MI is an independent Risk Factor for In-hospital Mortality !!! @escardio @ACCinTouch @rohandkumar1 @inacc @NEJMEvidence
51
“Not all MIs are the same” - First Blood Test Diagnostic of Hemorrhagic MI - First Clinical Trial of Post-PCI High Sensitvity Troponin Kinetics Study - First acute biomarker to stratify post-PCI patients in CCU⁦@rohandkumar1⁩ ⁦⁦@inaccmedicine.iu.edu/news/2025/08…
3
5
513
Keyur P. Vora retweeted
Live-Attenuated Intranasal RSV Vaccine in Infants and Toddlers eviden.cc/4fPl6MX An Individualized Prediction Model for Early-Stage Classic Hodgkin’s Lymphoma eviden.cc/43ZUl2O In-Hospital Mortality in Hemorrhagic Myocardial Infarction eviden.cc/47FEcTI
1
1
1
119
Keyur P. Vora retweeted
Scientists @KeyurVoraMD and @rohandkumar1 from Medical Imaging Research Institute @IUMedSchool will present their research in @NEJMEvidence at #ESCCongress2025 on Aug. 31, that shows how troponin can predict in-patient hospital deaths after #HemorrhagicMI shorturl.at/Nn5Fg
1
2
292
I’ll be attending the amazing Indiana-ACC Annual Meeting 2025 on September 13, 2025 at Marriott Indianapolis North. Let me know if you’re planning to attend so that we can say Hi! 👋 Or register now and join me at the event! whova.com/portal/registratio…
37
Honored to present at #ACCAsia on: In-hospital Mortality in Hemorrhagic Myocardial Infarction: Diagnostics to Implications Thank you @ACCinTouch & @SingCardiacSoc for the opportunity to share this work. Proud to represent @IURadiology & SCVRI India !!!
1
6
2,663
Keyur P. Vora retweeted
In this #JACCAdvances state-of-the-art review, Dr. Dharmakumar, et al explore advancements & challenges in #cvAMI management. They review 🔑 insights from the prereperfusion era & summarize observations in reperfusion therapy. Get the details: jacc.org/doi/10.1016/j.jacad… #cvMI
11
41
5,324
Keyur P. Vora retweeted
Top U.S. #cardiovascular researchers agree that not all #heartattacks are the same. Identifying extent of #myocardialtissue damage is critical they say in #JACCAdvances. medicine.iu.edu/blogs/cardio…
1
4
10
1,582
"Our State-of-the-Art Review traces the history of Myocardial Infarction. Despite decades of reperfusion advances, intramyocardial hemorrhage remains the missing key in post-MI care." @IUMedSchool @IUHealthFdn jacc.org/doi/10.1016/j.jacad…
1
59
Keyur P. Vora retweeted
#IUKrannertHeart investigator @KeyurVoraMD and collaborators, including @rohandkumar1 @IUMedSchool, shared findings from their MIRON-CL and MIRON-RUPTURE clinical trials at #AHA24 on innovative approaches to treating hemorrhagic MI.
1
3
220
Thank you JACC for recognising this critical aspect of STEMI Care !!!
In a heart attack, “time is muscle” & “time is vessel”? This state-of-the-art review summarizes the pathophysiology of microvascular injury after reperfusion in #cvAMI the consequences & contributions of #cvImaging including future trials & therapies. bit.ly/3Y363s7 #JACCIMG
1
179
Our First-in-human Clinical Trial of hemorrhagic MI treatment is going National !!!
Wow! Our March 5, 2024 AO RO1 submission for $3.2 million scored top 5% at @nih_nhlbi. This work is extension of our troponin kinetic data in #STEMI patients we presented at @CRT_meeting as late-breaking science in Mar ‘24. @rohandkumar1; congrats! You are the 🐐! @KeyurVoraMD
1
4
1,255
Lipoprotein(a) and coronary artery disease burden in patients with diabetes sciencedirect.com/science/ar… Lp(a) levels link to non-calcified plaque burden, not progression, suggesting targeted Lp(a) therapies and larger AI-QCT trials !!! @rohandkumar1 @HeartDocSubha @IUKrannertHeart

2
178